Shared Care Thyroid Cancer Follow-up Utilizing Thyroid Cancer Assessment Reminder System (TCARS) Study - A Pilot Study.
- Conditions
- Low Risk Differentiated Thyroid Cancer
- Registration Number
- NCT05510934
- Lead Sponsor
- Nova Scotia Health Authority
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria:<br><br>Adult (>18 years old) consenting patients being followed at the Halifax Interdisciplinary<br>Thyroid Oncology Clinic (ITOC) meeting the following criteria:<br><br> - AJCC stage 1 DTC with no radiological or biochemical evidence of thyroid cancer with<br> undetectable high sensitivity serum thyroglobulin (hsTG <0.06 mcg/L*);<br><br> - Anti-thyroglobulin antibody (anti-TG AB <20 IU/ml*);<br><br> - Thyroid ultrasound scan [USS] negative for regional recurrence at least 24 months<br> after most recent treatment;<br><br> - AJCC stage 2 DTC with no radiological or biochemical evidence of cancer<br> (undetectable hsTG and anti-TG AB and negative thyroid USS) at least 48 months after<br> most recent treatment<br><br> - Patient is comfortable with using the mobile or Medable application and has access<br> to internet.<br><br>Exclusion Criteria:<br><br>Patient does not have a consented PCP.
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Feasibility outcomes;DTC shared-care outcomes
- Secondary Outcome Measures
Name Time Method Patient satisfaction outcomes;Patient and provider acceptability and experience outcomes;PCP confidence in DTC management outcomes